Skip to main content
SpringerLink
Log in

Association Between Malignant Hyperthermia and Severe, Chronic Muscle Pain

  • Conference paper
Malignant Hyperthermia

Summary

The purpose of this study is to examine the relationship between anesthetic-induced malignant hyperthermia (MH) and severe, generalized, and persistent muscle pain. We have performed the caffeine-halothane contracture test (CHCT) (3% halothane-induced contractures, caffeine-specific concentrations [CSCs], and 2 mM caffeine-induced contractures) on 34 healthy volunteer controls, 114 patients who have had known or suspected malignant hyperthermic (MH) reactions, and 143 patients who have had severe and persistent muscle pain that has prevented full-time work. Serum creatine kinase (CK) levels, 3% halothane contractures, and 2 mM caffeine contractures were substantially greater and CSCs were significantly smaller in the MH and muscle pain (MP) patients than in the control patients. There were no significant differences in these parameters between the MH and the MP patients except that CK levels were greater in the MP than in the MH patients. There seem to be at least three possible scenarios for the etiology of MP. The first is that MP patients are simply MH genotypes who have not yet had an MH reaction. They possess the MH gene, and their symptoms are triggered by environmental factors such as excessive exercise, extreme heat or cold, infection, or chemicals in the workplace. The second is that MP individuals are actually chronic fatigue immune dysfunction syndrome (CFIDS) patients. It may be that muscle changes occur in CFIDS patients that mimic MH, at least so far as the CHCT is concerned. The third possibility is that the MP patients have some third, as yet unidentified, condition that is different from both MH and CFIDS. We have shown that a cohort of chronic muscle pain patients possess an organic muscle defect as evidenced by abnormal CHCTs even though the microscopic appearance of their muscles was normal and in spite of a lack of objective physical abnormalities. This defect is probably similar to MH, but whether it is identical to MH has not been shown by this study.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Poels PJE, Joosten EMG, Sengers RCA, Stadhouders AM, Veerkamp JH, Benders AAGM (1991) In vitro contraction test for malignant hyperthermia in patients with unexplained recurrent rhabdomyolysis. J Neurol Sci 105: 67–72

    Article  PubMed  CAS  Google Scholar 

  2. Gronert GA, Thompson RL, Onofrio BM (1980) Human malignant hyperthermia: awake episodes and correction by dantrolene. Anesth Analg 59: 377–378

    Article  PubMed  CAS  Google Scholar 

  3. Wingard D, Gatz EE (1977) Some observations on stress susceptible patients. In: Aldrete JA, Britt BA (eds) Second international symposium on malignant hyperthermia. Grune and Stratton, New York, pp 363–367

    Google Scholar 

  4. Wingard D (1977) Malignant hyperthermia—acute stress syndrome of man? In: Henschel EO (ed) Malignant hyperthermia current concepts. Appleton-CenturyCrofts, New York

    Google Scholar 

  5. Wingard DW (1980) A stressful situation. Anesth Anal 59: 1041–1042

    Article  Google Scholar 

  6. Wingard DW (1974) Malignant hyperthermia: a human stress syndrome? Lancet i: 408

    Google Scholar 

  7. Krivosec-Horber AP, Reyford H (1991) Relationship between exercise-induced myolysis and malignant hyperthermia. Br J Anaesth 67: 221–228

    Article  Google Scholar 

  8. Heytons L, Martin JJ, Van de Kelft E, Bossnert LL (1992) In vitro contracture tests in patients with various neuromuscular diseases. Br J Anaesth 68: 72–75

    Article  Google Scholar 

  9. Proceedings of a workshop on chronic fatigue syndrome, Toronto, Ontario, 28/29 September 1989. Organized by the Laboratory Centre for Disease Control, Health Protection Branch, Dept. of National Health and Welfare, Canada

    Google Scholar 

  10. Goldenberg D, Simms RW, Geiger A, Komaroff AL (1990) High frequency of fibromyalgia in patients with chronic fatigue seen in primary care practice. Arthritis Rheum 33: 381–387

    Article  PubMed  CAS  Google Scholar 

  11. Goldenberg D, Komaroff AL (1989) The chronic fatigue syndrome: definition, current studies and lessons for fibromyalgia research. J Rheumatol (suppl) 19: 23–27

    Google Scholar 

  12. Abbey SE, Garfinkel PE (1991) Neurasthenia and chronic fatigue syndrom. Am J Psychiatty 148: 1638–1646

    CAS  Google Scholar 

  13. Ichise M, Salit JE, Abbey SE, Chung D-G, Gray B, Kirsh JC, Freedman M (1992) Assessment of regional cerebral perfusion by technetium-99 m HM-PAO SPECT in chronic fatigue syndrome. Nucl Med Commun 13 (10): 767–772

    PubMed  CAS  Google Scholar 

  14. Ahles TA, Yunus MB, Masi AT (1987) Is chronic pain a variant of depressive illness? The case of primary fibromyalgia syndrome. Pain 29: 105–111

    Article  PubMed  CAS  Google Scholar 

  15. Buchwald D, Goldenberg DL, Sullivan JL, et al (1987) The chronic active Epstein-Barr virus infection syndrome and primary fibromyalgia. Arthritis Rheum 30: 1132–1136

    Article  PubMed  CAS  Google Scholar 

  16. David A, Wesseley S, Pelosi A (1988) Post viral fatigue: time for a new approach. Br Med J 296: 696–698

    Article  CAS  Google Scholar 

  17. Wesseley S (1990) Old wine in new bottles: neurasthenia and ME. Psychol Med 20: 35–53

    Article  Google Scholar 

  18. Arnold DL, Radde GK, Bore PJ, Styles P (1984) Excessive intracellular acidosis of skeletal muscle on exercise in a patient with a post-viral exhaustion/fatigue syndrome, Lancet 1: 293

    Google Scholar 

  19. Behan PO, Bchan WMH, Bell EJ (1985) The post-viral fatigue syndrome—an analysis of the findings in 50 cases. J Infection 10: 211–222

    Article  CAS  Google Scholar 

  20. Mildon A (1991) Chronic fatigue syndrome. Can Dis Wkly Rep (suppl) 17S1E: 18

    Google Scholar 

  21. Archard LC, Bowles NC, Behan PO, Bell EJ, Doyle D (1988) Postviral fatigue syndrome: persistence of enterovirus RNA in muscle and elevated creatine kinase. J R Soc Med 81: 326–329

    PubMed  CAS  Google Scholar 

  22. Russell IJ (1989) Neurohormonal aspects of fibromyalgia syndrome. Rheum Dis Clin North Am 15: 141

    Google Scholar 

  23. Montague TJ, Marrie TJ, Klassen GA, Bewick DJ, Horacek BM (1989) Cardiac function at rest and with exercise in the chronic fatigue syndrome. Chest 95: 779–784

    Article  PubMed  CAS  Google Scholar 

  24. Gow JW, Behan WMH, Clements GB, Woodall C, Riding M, Behan PO (1991) Enteroviral RNA sequences detected by polymerase chain reaction in muscle of patients with postviral fatigue syndrome. Br Med J 302: 692

    Article  CAS  Google Scholar 

  25. Ritz J (1989) The role of natural killer cells in immune surveillance (editorial). N Engl J Med 320: 1748–1749

    Article  PubMed  CAS  Google Scholar 

  26. Archard LC, Cunningham L (1992) Molecular virology of muscle disease: persistent virus infection of muscle in patients with postviral fatigue syndrome. In: Hyde BM, Goldstein J, Levine P (eds) The clinical and scientific basis of myalgic encephalitis/chronic fatigue syndrome. Nightingale Research Foundation, Ottawa, Canada, P 343

    Google Scholar 

  27. Klimas NG, Salvato FR, Morgan R, Fletcher MA (1990)) Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 18: 1403–1410

    Google Scholar 

  28. Landay AL, Jessop C, Lennette ET, Levy JA (1991) Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet 338: 707

    Article  PubMed  CAS  Google Scholar 

  29. Hickie I, Lloyd A, Wakefield D, Parker G (1990) The psychiatric status of patients with chronic fatigue syndrome. Br J Psychiatry 156: 534–540

    Article  PubMed  CAS  Google Scholar 

  30. Holmes GP, Kaplan JE, Grantz NM, et al (1988) Chronic fatigue syndrome: a working case definition. Ann Intern Med 108: 387–389

    PubMed  CAS  Google Scholar 

  31. Cody RP, Smith JK (1991) Applied statistics and the SAS programming language. North-Holland, New York

    Google Scholar 

  32. Britt BA (1991) Malignant hyperthermia—a review. In: Schonbaum E, Lomax P (eds) Thermoregulation: pathology, pharmacology and therapy. Pergamon Press, New York, pp 179–292

    Google Scholar 

  33. Larach MG (1989) Standardization of the caffeine halothane muscle contracture test. Anesth Analg 69: 511–515

    Article  PubMed  CAS  Google Scholar 

  34. Gronert GA, Chun K, Martucci R, Jones BR (1990) Concentration of halothane in Kreb’s medium. Anesth Analg 71: 305–314

    Article  Google Scholar 

  35. Larach MG, Localio AR, Allen GC, Denborough MA, Ellis FR, Gronert GA, Kaplan RF, Muldoon SM, Nelson TE, Ording H, Rosenberg H, Waud B (1994) A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology 80: 771–779

    Article  PubMed  CAS  Google Scholar 

  36. Britt BA, Endrenyi L, Peters PL, et al (1976) Screening of malignant hyperthermic susceptible families by CPK measurement and other clinical investigations. Can Anaesth Soc J 23: 263–284

    Article  PubMed  CAS  Google Scholar 

  37. Ellis FR, Clarke IMC, Modgill M, Currie S, Harriman DGF (1975) Evaluation of creatine phosphokinase in screening patients for malignant hyperpyrexia. Br Med J 3: 511–513

    Article  PubMed  CAS  Google Scholar 

  38. Paasuke RT, Brownell KW (1986) Serum creatine kinase level as a screening test for susceptibility to malignant hyperthermia. JAMA 255: 769–771

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Malignant Hyperthermia Investigation Unit, Department of Anaesthesia, University of Toronto, Toronto General Hospital, Toronto, Ontario, M5G 2C4, Canada

    Beverley A. Britt, C. Anne Mildon, Wanda Frodis & Elizabeth Scott

Authors
  1. Beverley A. Britt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Anne Mildon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wanda Frodis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elizabeth Scott
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Chugoku Rosai General Hospital, Hiroshima University, 737-01, Kure, Hiroshima, Japan

    Michio Morio M.D., Ph.D. (Professor Emeritus, Director General) (Professor Emeritus, Director General)

  2. The First Department of Anesthesiology, Toho University School of Medicine, Ohta-ku, Tokyo, 143, Japan

    Hirosato Kikuchi M.D., Ph.D. (Chairman and Professor) (Chairman and Professor)

  3. Department of Anesthesiology and Critical Care Medicine, Hiroshima University School of Medicine, Hiroshima, 734, Japan

    Osafumi Yuge M.D., Ph.D. (Professor and Chairman) (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Tokyo

About this paper

Cite this paper

Britt, B.A., Mildon, C.A., Frodis, W., Scott, E. (1996). Association Between Malignant Hyperthermia and Severe, Chronic Muscle Pain. In: Morio, M., Kikuchi, H., Yuge, O. (eds) Malignant Hyperthermia. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68346-9_20

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-68346-9_20

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-68348-3

  • Online ISBN: 978-4-431-68346-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation